Fibromuscular dysplasia

disease
On this page

Also known as fibromuscular dysplasia of arteriesFMDA

Summary

Fibromuscular dysplasia (MONDO:0006761) is a disease (an umbrella term covering 5 Mondo subtypes) with 32 GWAS associations across 1 studies and 15 clinical trials. A subtype of arterial disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Umbrella term: 5 Mondo subtypes
  • GWAS associations: 32
  • Clinical trials: 15

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namefibromuscular dysplasia
Mondo IDMONDO:0006761
EFOEFO:1000938
MeSHC537929, D005352
OMIM135580
Orphanet336, 698012
ICD-11280853107
NCITC84714
UMLSC0016052
MedGen4700
GARD0027765
MedDRA10054794
Is cancer (heuristic)no

Also known as: fibromuscular dysplasia · fibromuscular dysplasia of arteries · FMDA

Data availability: 32 GWAS associations (1 study) · 31 cell lines.

Disease family

This is a subtype of arterial disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › cardiovascular disordervascular disorderarterial disorderfibromuscular dysplasia

Related subtypes (29): vertebral artery insufficiency, splenic artery aneurysm, basilar artery insufficiency, arteriosclerosis disorder, subclavian artery aneurysm, pulmonary artery choriocarcinoma, pulmonary artery leiomyosarcoma, coronary artery disorder, hypertensive disorder, carotid artery disorder, pulmonary embolism, peripheral arterial disease, hypotensive disorder, large artery stroke, aortic disorder, cervical artery dissection, anterior spinal artery syndrome, retinal arterial tortuosity, Sneddon syndrome, celiac trunk compression syndrome, pediatric arterial ischemic stroke, absence of the pulmonary artery, arterial occlusion, aberrant subclavian artery, anterior spinal artery stroke, arteritis, pulmonary artery disease, fibromuscular dysplasia, multifocal, carotid web

Subtypes (5): fibromuscular dysplasia of the cervical and intracranial arteries, fibromuscular dysplasia of the renal arteries, fibromuscular dysplasia of the coronary arteries, fibromuscular dysplasia of the visceral arteries, fibromuscular dysplasia of the arteries of the extremities

Genetics & variants

GWAS landscape

32 GWAS associations across 1 studies. Top hits map to 22 distinct genes (as reported by GWAS).

Top associations by p-value

rsIDp-valueGeneRisk alleleOdds ratio
rs93493795e-15PHACTR1A1.44
rs111721132e-10LRP1T1.34
rs73015664e-09LIMA1T1.29
rs26814922e-08ATP2B1T1.43
rs728028731e-07LINC01470C0.55
rs715267595e-07RPSAP48 - NDUFB9P3T0.44
rs95083095e-07MTUS2G0.3
rs25907846e-07LNX1 - RPL21P44T0.22
rs1994548e-07NSFA0.26
rs17773358e-07SVILC0.21
rs619417331e-06Y_RNA - LINC02409A0.47
rs77454601e-06FAM184AG0.36
rs70728772e-06RN7SKP167 - FGFR2T0.23
rs16522443e-06FRMPD2G0.21
rs108409123e-06Y_RNA - RERGLT0.23
rs23832063e-06CDKN2B-AS1G0.2
rs46536943e-06EPHX1C0.31
rs559800664e-06ZMAT4T0.2
rs24242454e-06SLC24A3C0.32
rs793416714e-06MAP3K7 - MIR4643G0.6
rs69125725e-06UFL1-AS1C0.23
rs117597695e-06FHL5A0.23
rs111009015e-06ZNF827T0.23
rs726751576e-06SLC25A3P1 - DMRTB1C0.83
rs746370147e-06NUS1P2 - HMGA1P6C0.32
rs414445487e-06TBX21G0.36
rs122263967e-06MIR4299 - MIR8070C0.32
rs111400308e-06FRMD3T0.27
rs131983978e-06LINC02534 - FRKC0.35
rs1150740939e-06CARMIL1G0.34

Top studies (by case count)

StudyLead authorYearCasesControlsTitle
GCST90026612Georges A20211,5567,100Genetic investigation of fibromuscular dysplasia identifies risk loci and shared genetics with common cardiovascular diseases.

Variant details and genetic-evidence tiers

Tier distribution (top 50 variants)

TierVariants
Tier 1: coding0
Tier 2: splice/UTR2
Tier 3: regulatory0
Tier 4: intronic/intergenic30

MAF distribution

BucketVariants
common (>=0.05)29
low_freq (0.01-0.05)3
rare (<0.01)0
unknown0

Functional consequences

ConsequenceCount
intron_variant21
intergenic_variant6
non_coding_transcript_exon_variant3
3_prime_UTR_variant2

Top variants

rsIDChrPosAllelesMAFConsequenceGenep-valueTier
rs9349379612903725A>C,G,T0.37intron_variantPHACTR15e-15Tier 4: intronic/intergenic
rs111721131257133500T>C,G0.38intron_variantLRP12e-10Tier 4: intronic/intergenic
rs73015661250187864T>A,C,G0.45non_coding_transcript_exon_variantLIMA14e-09Tier 4: intronic/intergenic
rs26814921289619312T>A,C,G0.16intron_variantATP2B12e-08Tier 4: intronic/intergenic
rs728028735152859622G>C0.035intron_variantLINC014701e-07Tier 4: intronic/intergenic
rs715267598110484431C>T0.054intergenic_variantRPSAP48 - NDUFB9P35e-07Tier 4: intronic/intergenic
rs95083091329183368A>G0.139intron_variantMTUS25e-07Tier 4: intronic/intergenic
rs2590784453709265C>T0.345intron_variantLNX1 - RPL21P446e-07Tier 4: intronic/intergenic
rs1994541746722744G>A0.313intron_variantNSF8e-07Tier 4: intronic/intergenic
rs17773351029703755C>G,T0.479intron_variantSVIL8e-07Tier 4: intronic/intergenic
rs619417331297212760G>A0.045non_coding_transcript_exon_variantY_RNA - LINC024091e-06Tier 4: intronic/intergenic
rs77454606119075034A>G0.083intron_variantFAM184A1e-06Tier 4: intronic/intergenic
rs707287710121469146C>A,G,T0.253intergenic_variantRN7SKP167 - FGFR22e-06Tier 4: intronic/intergenic
rs16522441048250706G>A,C,T0.427intron_variantFRMPD23e-06Tier 4: intronic/intergenic
rs108409121217865410C>T0.271intergenic_variantY_RNA - RERGL3e-06Tier 4: intronic/intergenic
rs2383206922115027A>G0.475intron_variantCDKN2B-AS13e-06Tier 4: intronic/intergenic
rs46536941225841073A>C,G,T0.101non_coding_transcript_exon_variantEPHX13e-06Tier 4: intronic/intergenic
rs55980066840760335C>T0.378intron_variantZMAT44e-06Tier 4: intronic/intergenic
rs24242452019669072C>T0.135intron_variantSLC24A34e-06Tier 4: intronic/intergenic
rs79341671691409896G>A0.058intron_variantMAP3K7 - MIR46434e-06Tier 4: intronic/intergenic
rs6912572696267852T>A,C,G0.323intron_variantUFL1-AS15e-06Tier 4: intronic/intergenic
rs11759769696617336G>A0.2363_prime_UTR_variantFHL55e-06Tier 2: splice/UTR
rs111009014145825808C>T0.221intron_variantZNF8275e-06Tier 4: intronic/intergenic
rs72675157153447066G>C0.017intron_variantSLC25A3P1 - DMRTB16e-06Tier 4: intronic/intergenic
rs746370141322971858C>G,T0.12intron_variantNUS1P2 - HMGA1P67e-06Tier 4: intronic/intergenic
rs414445481747733988C>G,T0.065intron_variantTBX217e-06Tier 4: intronic/intergenic
rs122263961111689194C>A,G,T0.126intergenic_variantMIR4299 - MIR80707e-06Tier 4: intronic/intergenic
rs11140030983329543C>A,T0.142intron_variantFRMD38e-06Tier 4: intronic/intergenic
rs131983976115782595C>T0.196intergenic_variantLINC02534 - FRK8e-06Tier 4: intronic/intergenic
rs115074093625543685T>G0.074intron_variantCARMIL19e-06Tier 4: intronic/intergenic

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 15.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified14
PHASE11

Top trials by phase / activity

NCTPhaseStatusTitle
NCT03335020PHASE1WITHDRAWNUsing Ultrasonography, Shear Wave Elastography, Strain Imaging, and 3-D Volume Ultrasonography on Cardiovascular Disease
NCT01967511Not specifiedRECRUITINGDefining the Basis of Fibromuscular Dysplasia (FMD)
NCT04804683Not specifiedRECRUITINGEuropean/International FMD Registry and Initiative
NCT04906356Not specifiedRECRUITINGCanadian SCAD Study
NCT05491980Not specifiedACTIVE_NOT_RECRUITINGFlorida Cerebrovascular Disease Biorepository and Genomics Center
NCT05628948Not specifiedRECRUITINGVascular Lab Resource (VLR) Biorepository
NCT06065852Not specifiedRECRUITINGNational Registry of Rare Kidney Diseases
NCT07526766Not specifiedRECRUITINGA Study Of Exercise In Patients With Spontaneous Coronary Artery Dissection And Fibromuscular Dysplasia
NCT07529691Not specifiedRECRUITINGSurvey on Physical Activity and Qualify of Life in Fibromuscular Dysplasia
NCT01808729Not specifiedCOMPLETEDCAUSE Trial: Patient Specific-Cellular Characterization of Fibromuscular Dysplasia and High-Risk Atherosclerotic Endothelium
NCT01935752Not specifiedCOMPLETEDPathophysiological Mechanisms of Fibromuscular Dysplasia
NCT02528149Not specifiedCOMPLETEDRenal Arteries Dysplastic Aneurysms: Anatomopathological and Genetic Study
NCT02884141Not specifiedCOMPLETEDCross-sectional Study of Patients With Renal or Craniocervical Fibromuscular Dysplasia
NCT02961868Not specifiedCOMPLETEDCohort Follow-up of Patients With Renal or Craniocervical Fibromuscular Dysplasia
NCT03596437Not specifiedUNKNOWNStudy of Arterial Properties by Ultra-high Frequency Ultrasound in Fibromuscular Dysplasia and Vascular Ehlers-Danlos Syndrome

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.